Literature DB >> 1587187

Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis.

J R Murphy1, P McNally, P Peller, S S Shay.   

Abstract

The purpose of this study is to determine if frequent reflux events from an incompetent LES or poor clearance from decreased peristalsis is the predominant abnormality in PSS patients with severe reflux esophagitis. Seven patients with both classic manometric findings of PSS and endoscopic findings of esophageal ulcerations and/or Barrett's esophagus were compared to nine patients with similar endoscopic findings but with no evidence of a connective tissue disorder. All patients underwent simultaneous intraesophageal pH monitoring and scintigraphy for a total of 40 min after a radiolabeled meal. Four of the PSS patients and all the non-PSS patients had simultaneous manometry. We found that PSS patients had significantly fewer reflux events (P less than 0.01), but the reflux events had significantly longer duration (P less than 0.01) compared to patients with similar severity of esophagitis and no connective tissue disease. We conclude that decreased smooth muscle peristalsis appears to be the primary contributor to acid exposure and esophageal injury in PSS.

Entities:  

Mesh:

Year:  1992        PMID: 1587187     DOI: 10.1007/bf01300380

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Esophageal motility in patients with scleroderma and related diseases.

Authors:  B CREAMER; H A ANDERSEN; C F CODE
Journal:  Gastroenterologia       Date:  1956

2.  Instrumentation and methods for intraluminal esophageal manometry.

Authors:  W J Dodds
Journal:  Arch Intern Med       Date:  1976-05

3.  Esophageal manometry and pH-probe monitoring in the evaluation of gastroesophageal reflux in patients with progressive systemic sclerosis.

Authors:  P Stentoft; L Hendel; S Aggestrup
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

4.  Esophageal deterioration in scleroderma.

Authors:  J M Garrett; R K Winkelmann; J F Schlegel; C F Code
Journal:  Mayo Clin Proc       Date:  1971-02       Impact factor: 7.616

5.  Effect of esophageal emptying and saliva on clearance of acid from the esophagus.

Authors:  J F Helm; W J Dodds; L R Pelc; D W Palmer; W J Hogan; B C Teeter
Journal:  N Engl J Med       Date:  1984-02-02       Impact factor: 91.245

6.  Oesophageal changes in systemic sclerosis.

Authors:  M Atkinson; M D Summerling
Journal:  Gut       Date:  1966-08       Impact factor: 23.059

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  The gastrointestinal manifestations of scleroderma: pathogenesis and management.

Authors:  S Cohen
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

9.  Cycling, a manometric phenomenon due to repetitive episodes of gastroesophageal reflux and clearance.

Authors:  S S Shay; D Eggli; G Oliver; D A Peura; L F Johnson
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

10.  Radionuclide esophageal transit. A screening test for esophageal disorders.

Authors:  D Netscher; G M Larson; H C Polk
Journal:  Arch Surg       Date:  1986-07
View more
  10 in total

1.  Relation between esophageal acid exposure and esophageal peristalsis.

Authors:  Joseph C Yarze
Journal:  Dig Dis Sci       Date:  2008-01-19       Impact factor: 3.199

2.  Reproducibility of ambulatory esophageal pH monitoring in the aperistaltic esophagus.

Authors:  J P Shoenut; A B Mieflikier; T A Aldor; C S Yaffe; D J Goldenberg
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

3.  Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis.

Authors:  M Wegener; R J Adamek; B Wedmann; M Jergas; P Altmeyer
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

4.  Esophageal disease in progressive systemic sclerosis.

Authors:  Ellen C Ebert
Journal:  Curr Treat Options Gastroenterol       Date:  2008-02

Review 5.  Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Authors:  Daniel E Furst; Yolanda Braun-Moscovic; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

6.  Acid clearance and oesophageal sensitivity in patients with progressive systemic sclerosis.

Authors:  G Basilisco; R Barbera; M Molgora; M Vanoli; P Bianchi
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

7.  Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience.

Authors:  Catherine H Miele; Kristin Schwab; Rajeev Saggar; Erin Duffy; David Elashoff; Chi-Hong Tseng; Sam Weigt; Deepshikha Charan; Fereidoun Abtin; Jimmy Johannes; Ariss Derhovanessian; Jeffrey Conklin; Kevin Ghassemi; Dinesh Khanna; Osama Siddiqui; Abbas Ardehali; Curtis Hunter; Murray Kwon; Reshma Biniwale; Michelle Lo; Elizabeth Volkmann; David Torres Barba; John A Belperio; David Sayah; Thomas Mahrer; Daniel E Furst; Suzanne Kafaja; Philip Clements; Michael Shino; Aric Gregson; Bernard Kubak; Joseph P Lynch; David Ross; Rajan Saggar
Journal:  Ann Am Thorac Soc       Date:  2016-06

8.  Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.

Authors:  Tasleem Arif; Qazi Masood; Jaswinder Singh; Iffat Hassan
Journal:  BMC Gastroenterol       Date:  2015-02-15       Impact factor: 3.067

Review 9.  Evaluation and management of esophageal manifestations in systemic sclerosis.

Authors:  Konstantinos Denaxas; Spyros D Ladas; George P Karamanolis
Journal:  Ann Gastroenterol       Date:  2018-01-18

10.  Gastroesophageal reflux disease in our asthma patients: the presence of dysphagia can influence pulmonary function.

Authors:  Gulfidan Aras; Dilek Kanmaz; Figen Kadakal; Sevim Purisa; Kenan Sonmez; Esin Tuncay; Arzu Ozdemir
Journal:  Multidiscip Respir Med       Date:  2012-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.